An update on the use of degarelix in the treatment of advanced hormone-dependent prostate cancer

Androgen deprivation therapy remains the mainstay of medical treatment for advanced prostate cancer. Commonly, this is achieved with medical androgen deprivation rather than surgical intervention as the permanence and psychological effects of the latter are unacceptable for most patients. Degarelix...

Descripción completa

Detalles Bibliográficos
Autores principales: Rick, Ferenc G, Block, Norman L, Schally, Andrew V
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3633549/
https://www.ncbi.nlm.nih.gov/pubmed/23620672
http://dx.doi.org/10.2147/OTT.S32426

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3633549/
https://www.ncbi.nlm.nih.gov/pubmed/23620672
http://dx.doi.org/10.2147/OTT.S32426

Ejemplares similares